Consonni, D. (Dario)

Filtering

2012 - 20202

Settings

Author search.filters.isAuthorOfPublication.dcd89698-4415-4ccc-b2d2-65360a44afdc

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe
    (MDPI AG, 2020) Bonomo, L. (Lorenzo); Rossi, A. (Alexia); Vittorio-Scagliotti, G. (Giorgio); Brain, K. (Kate); Senan, S. (Suresh); Ferrante, G. (Giuseppe); Valentino-Infante, M. (Maurizio); Van-Meerbeeck, J.P. (Jan P.); Horgan, D. (Denis); Rocco, G. (Gaetano); Baldwin, D.R. (David R.); Rampinelli, C. (Cristiano); Triphuridet, N. (Natthaya); Ghislandi, S. (Simone); Field, J.K. (J. K.); Henschke, C.I. (C.I.); De-Koning, H.J. (Harry J.); Novello, S. (S.); Saghir, Z. (Zaigham); Saghir, G. (Giuseppe); Rzyman, W. (Witold); Bertolaccini, L. (Luca); Fiestas-Navarrete, L. (Lucía); Veronesi, G. (Giulia); Maisonneuve, P. (Patrick); Peled, N. (Nir); Consonni, D. (Dario); Oudkerk, M. (Matthijs); Novellis, P. (Pierluigi); Aalst, C. (Carlijn) van der; Shemesh, J. (Joseph); Tammemagi, M.C. (Martin C.); Devaraj, A. (Anand); Iavicoli, S. (Sergio); Yip, R. (Rowena); Zulueta, J. (Javier); Murray, R.L. (Rachael L.)
    Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the disease. European mortality data has recently become available from the Nelson randomised controlled trial, which confirmed lung cancer mortality reductions by 26% in men and 39–61% in women. Recent studies in Europe and the USA also showed positive results in screening workers exposed to asbestos. All European experts attending the “Initiative for European Lung Screening (IELS)”—a large international group of physicians and other experts concerned with lung cancer—agreed that LDCT-LCS should be implemented in Europe. However, the economic impact of LDCT-LCS and guidelines for its effective and safe implementation still need to be formulated. To this purpose, the IELS was asked to prepare recommendations to implement LCS and examine outstanding issues. A subgroup carried out a comprehensive literature review on LDCT-LCS and presented findings at a meeting held in Milan in November 2018. The present recommendations reflect that consensus was reached.
  • Thumbnail Image
    Detectable clonal mosaicism and its relationship to aging and cancer
    (Nature Publishing Group, 2012-12) Johnson, A. (Alison); Goldstein, A.M. (Alisa M.); Hu, N. (Nan); Koh, W.P. (Woon-Puay); Landgren, A. (Annelie); Stevens, V.L. (Victoria L.); Wiencke, J.K. (John K.); Hunter, D.J. (David J.); Patiño-García, A. (Ana); Khaw, K.T. (Kay-Tee); Virtamo, J. (Jarmo); Schwartz, A.G. (Ann G.); Yuan, J.M. (Jian-Min); Rybicki, B.A. (Benjamin A.); Boutron-Ruault, M.C. (Marie-Christine); Wolk, A. (Alicja); Mandelson, M.T. (Margaret T.); McGlynn, K.A. (Katherine A.); Hankinson, S.E. (Susan E.); Liao, L. (Linda); Fuchs, C.S. (Charles S.); Zhou, W. (Weiyin); Erickson, R.L. (Ralph L.); Silverman, D.T. (Debra T.); Sampson, J. (Joshua); Hassan, M. (Manal); McNeill, L.H. (Lorna H.); Li, D. (Donghui); McWilliams, R.R. (Robert R.); Zheng, W. (Wei); Olson, S.H. (Sara H.); Thomas, G. (Gilles); Tang, Z.Z. (Ze-Zhong); Arslan, A.A. (Alan A.); Jenab, M. (Mazda); Elena, J.W. (Joanne W.); Rabe, K.G. (Kari G.); Villa, O. (Olaya); Wolpin, B.M. (Brian M.); Canzian, F. (Federico); Amundadottir, L. (Laufey); Qiao, Y.L. (You-Lin); Butler, M.A. (Mary A.); Cotterchio, M. (Michelle); Schwartz, K.L. (Kendra L.); Liu, C. (Chenwei); Kogevinas, M. (Manolis); Purdue, M. (Mark); Hoover, R.N. (Robert N.); Davis, F.G. (Faith G.); Johansen, C. (Christoffer); Lissowska, J. (Jolanta); Mendelsohn, J.B. (Julie B.); Hutchinson, A. (Amy); Kooperberg, C. (Charles); Marenne, G. (Gaelle); Freedman, N.D. (Neal D.); Sesso, H.D. (Howard D.); Stram, D. (Daniel); Wunder, J.S. (Jay S.); Harris, C.C. (Curtis C.); Jiao, L. (Li); Henderson, B.E. (Brian E.); Petersen, G. (Gloria); Stolzenberg-Solomon, R.Z. (Rachael Z.); Ahlbom, A. (Anders); Wentzensen, N. (Nicolas); Garcia-Closas, M. (Montserrat); Wacholder, S. (Sholom); McKean-Cowdin, R. (Roberta); Brinton, L.A. (Louise A.); Zeleniuch-Jacquotte, A. (Anne); Duell, E.J. (Eric J.); Andersson, U. (Ulrika); Beane-Freeman, L.E. (Laura E.); Kovaks, J. (Joseph); Berg, C.D. (Christine D.); Gallinger, S. (Steven); Zanetti, K.A. (Krista A.); Sierrasesumaga, L. (Luis); Blot, W.J. (William J.); Teras, L.R. (Lauren R.); Wang, Z. (Zhaoming); Fraumeni, J.F. (Joseph F.); Schwenn, M. (Molly); White, E. (Emily); Kraft, P. (Peter); Buring, J.E. (Julie E.); Giovannucci, E.L. (Edward L.); Figueroa, J.D. (Jonine D.); Albanes, D. (Demetrius); Chung, C.C. (Charles C.); Hoffman-Bolton, J.A. (Judith A.); Tobias, G.S. (Geoffrey S.); Severi, G. (Gianluca); Mirabello, L. (Lisa); Prokunina-Olsson, L. (Ludmila); Burdett, L. (Laurie); Barkauskas, D.A. (Donald A.); Feychting, M. (Maria); Haiman, C.A. (Christopher A.); Black, A. (Amanda); Michaud, D.S. (Dominique S.); Holly, E.A. (Elizabeth A.); Cook, M.B. (Michael B.); Ruder, A.M. (Avima M.); Gorlick, R.G. (Richard G.); Wrensch, M. (Margaret); Peplonska, B. (Beata); LaCroix, A. (Andrea); Weinstein, S.J. (Stephanie J.); Chow, W.H. (Wong-Ho); Gaziano, J.M. (J. Michael); Caporaso, N.E. (Neil E.); Chang, K. (Kenneth); Shu, X.O. (Xiao-Ou); Hsing, A.W. (Ann W.); Gonzalez, J.R. (Juan R.); Bock, C.H. (Cathryn H.); Real, F.X. (Francisco X.); Kratz, C.P. (Christian P.); Yu, K. (Kai); Rotunno, M. (Melissa); Gaudet, M.M. (Mia M.); Consonni, D. (Dario); Kolonel, L.N. (Laurence N.); Malats, N. (Nuria); Visvanathan, K. (Kala); Savage, S.A. (Sharon A.); Aldrich, M.C. (Melinda C.); Chanock, S.J. (Stephen J.); Bracci, P.M. (Paige M.); Rodriguez-Santiago, B. (Benjamin); Riboli, E. (Elio); Baris, D. (Dalsu); Klein, A.P. (Alison P.); Spitz, M.R. (Margaret R.); Deng, X. (Xiang); Risch, H.A. (Harvey A.); Perez-Jurado, L.A. (Luis A.); Gross, M.D. (Myron D.); Gillanders, E.M. (Elizabeth M.); Taylor, P.R. (Philip R.); Jacobs, K. (Kevin); Ding, T. (Ti); Hartge, P. (Patricia); Greene, M.H. (Mark H.); Abnet, C.C. (Christian C.); Wu, Y.Q. (Yan Q.); Peters, U. (Ulrike); Trichopoulos, D. (Dimitrios); Landi, M.T. (María Teresa); Horner, M.J. (Marie-Josephe); Le-Marchand, L. (Loic); Goldin, L. (Lynn); Gao, Y.T. (Yu-Tang); Fan, J.H. (Jin-Hu); Berndt, S.I. (Sonja I.); Epstein, C.G. (Caroline G.); Signorello, L.B. (Lisa B.); Chatterjee, N. (Nilanjan); Cullen, M. (Michael); Moore, L.E. (Lee E.); Wheeler, W. (William); Melin, B.S. (Beatrice S.); Giles, G.G. (Graham G.); Tjonneland, A. (Anne); Inskip, P.D. (Peter D.); Krogh, V. (Vittorio); Amos, C. (Christopher); Graubard, B.I. (Barry I.); Bertazzi, P.A. (Pier Alberto); Yeager, M. (Meredith); Goggins, M. (Michael); Yu, H. (Herbert); Tucker, M. (Margaret); Schumacher, F. (Fredrick); Carreon, T. (Tania); Ziegler, R.G. (Regina G.); Kurtz, R.C. (Robert C.); Henriksson, R. (Roger); Gapstur, S.M. (Susan M.); Hallmans, G. (Goran); Xiang, Y.B. (Yong-Bing); Bueno-de-Mesquita, H.B. (H. Bas); Rothman, N. (Nathaniel); Andrulis, I.L. (Irene L.); Dean, M.C. (Michael C.); Rajaraman, P. (Preetha)
    In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide association studies, we observed large chromosomal abnormalities in a subset of clones in DNA obtained from blood or buccal samples. We observed mosaic abnormalities, either aneuploidy or copy-neutral loss of heterozygosity, of >2 Mb in size in autosomes of 517 individuals (0.89%), with abnormal cell proportions of between 7% and 95%. In cancer-free individuals, frequency increased with age, from 0.23% under 50 years to 1.91% between 75 and 79 years (P = 4.8 × 10(-8)). Mosaic abnormalities were more frequent in individuals with solid tumors (0.97% versus 0.74% in cancer-free individuals; odds ratio (OR) = 1.25; P = 0.016), with stronger association with cases who had DNA collected before diagnosis or treatment (OR = 1.45; P = 0.0005). Detectable mosaicism was also more common in individuals for whom DNA was collected at least 1 year before diagnosis with leukemia compared to cancer-free individuals (OR = 35.4; P = 3.8 × 10(-11)). These findings underscore the time-dependent nature of somatic events in the etiology of cancer and potentially other late-onset diseases.